TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06378619

Intervention type: DIAGNOSTIC_TEST
Intervention: Tapping Test
Description: For the administration of the tapping test, a computer application installed on a Tablet will be used. The test will be administered up to 3 times, with a 15-minute interval between each administration. Each tapping test trial will last 15 seconds. At the beginning of the session, the patient will perform 2 practice attempts.

Intervention type: DIAGNOSTIC_TEST
Intervention: Tapping Test
Description: For the administration of the tapping test, a computer application installed on a Tablet will be used. The test will be administered up to 3 times, with a 15-minute interval between each administration. Each tapping test trial will last 15 seconds. At the beginning of the session, the patient will perform 2 practice attempts.

Intervention type: DIAGNOSTIC_TEST
Intervention: Archimedes Spiral
Description: For the administration of the Archimedean spiral, a computer application installed on a Tablet will be used. The Tablet screen will display a drawing of the spiral, serving as a reference for the participant. The test will be administered up to 3 times, with a 15-minute interval between each administration. At the beginning of the session, the patient will perform 2 practice attempts.

Intervention type: DIAGNOSTIC_TEST
Intervention: Archimedes Spiral
Description: For the administration of the Archimedean spiral, a computer application installed on a Tablet will be used. The Tablet screen will display a drawing of the spiral, serving as a reference for the participant. The test will be administered up to 3 times, with a 15-minute interval between each administration. At the beginning of the session, the patient will perform 2 practice attempts.
Study: NCT04219501

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VIVO
Description: Non-invasive mapping system software product that combines patient-specific images (MRI or CT) of the torso and cardiac structures and a 3D image of the torso that identifies precise ECG lead placement to generate a 3D model of the patient's heart.
Study: NCT05951049

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AT02
Description: Dosage Form: Solution for injection/infusion Dosage level: Different dose levels of AT02 Route of Administration: Intravenous use
Study: NCT06369805

Intervention type: OTHER
Intervention: there is no intervention
Description: there is no intervention
Study: NCT04788238

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dual-Task Zumba Gold
Description: Dual-Task Zumba Gold is a 12-week program to be conducted thrice weekly for 45-60 minutes. The intervention involves the concurrent performance of cognitive tasks and physical movements during specific parts of the dance. The activity will begin with warm-up and end with cool-down periods, at 5 to 10 minutes each. Orientation training will be done during the warm-up period, by asking questions to participants about time, place, and person. In the actual dance (30 to 40 minutes), the following domains will be trained: executive function (forward and backward serial counting); perceptual-motor ability (performing arm clock positions based on instructions); memory (forward and backward repetition of number/word series), and attention (forward and backward spelling of 3- to 5-letter words). The cool-down period will incorporate memory training by reminding the participants to summarize the activities performed.
Study: NCT04855981

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: whole body vibration
Description: All participants in the WBV group will perform the WBV training on a vibrating device (Confidence Vibration Plate Power Plus, China), which produces a lateral peak-to-peak oscillation. They will stand on the WBV platform with a 150° knee angle during the exposure minute. They started the training with three sets of 1 min separated by a 1-min resting period and vibration amplitude of 1 mm. They will add one set every session until they performed 10 sets of WBV. The frequency started at 20 Hz, which will be increased gradually by 2 Hz every 2 weeks +magnesium (Mg) (250 g) and vitamin B6 supplementation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aerobic exercise
Description: the subjects will receive aerobic exercises+ magnesium (Mg) (250 g) and vitamin B6 supplementation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: supplementation
Description: the subjects will receive magnesium (Mg) (250 g) and vitamin B6 supplementation

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: supplementation
Description: the subjects will receive magnesium (Mg) (250 g) and vitamin B6 supplementation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: supplementation
Description: the subjects will receive magnesium (Mg) (250 g) and vitamin B6 supplementation
Study: NCT05825495

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dinalbuphine sebacate
Description: A single dose of 150 mg dinalbuphine sebacate will be intragluteally administrated at least 12 hours before surgery.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Routine practice
Description: Within 3 days after surgery, paracoxib will be administrated twice a day. Ketorolac will intravenously give once breakthrough pain occurring. Enteral acetaminophen will be take regularly within 14 days after surgery.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine practice
Description: Within 3 days after surgery, paracoxib will be administrated twice a day. Ketorolac will intravenously give once breakthrough pain occurring. Enteral acetaminophen will be take regularly within 14 days after surgery.
Study: NCT05919966

Intervention type: OTHER
Intervention: Chlorhexidine bathing
Description: The procedure involved pouring an entire bottle (200ml) of 2% CHG solution (PBF Biotech, Taipei, Taiwan) onto a pre-packed set of eight single-use cotton wipes before each bathing session. A minimum of six wipes were required to thoroughly cover the entire body, including the bilateral upper and lower extremities, front and back of the trunk, perineum, and buttocks.
Study: NCT04617769

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Description: psychoeducational materials on trauma and safety behaviors

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Psychoeducation
Description: psychoeducational materials on trauma and safety behaviors

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation
Description: psychoeducational materials on trauma and safety behaviors

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure
Description: six 3-minute video exposure trials with an inter-trial interval of 2 minutes

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exposure
Description: six 3-minute video exposure trials with an inter-trial interval of 2 minutes
Study: NCT05697471

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dienogest
Description: Dienogest 2 mg per day

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Danazol
Description: Danzol 200MG per day
Study: NCT05396430

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Urinary catheter
Description: Duration of planned urinary cathterization following cesarean delivery

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Urinary catheter
Description: Duration of planned urinary cathterization following cesarean delivery

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Urinary catheter
Description: Duration of planned urinary cathterization following cesarean delivery
Study: NCT05269381

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Neoantigen Peptide Vaccine
Description: Receive personalized neoantigen vaccine SC

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sargramostim
Description: Given SC
Study: NCT04872257

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Vitamin D
Description: Vitamin D 5,000 UI for 6 months (oral capsule, daily, single-dose)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: NB-UVB Phototherapy
Description: NB-UVB Phototherapy twice per week for 6 months until completing 48 sessions. Initial dose of 200 mJ/cm² with a 10-20% increase to the previous session. Maximum dose for face and neck is 1500 mJ/cm² and 3000 mJ/cm² for the rest of the body.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: NB-UVB Phototherapy
Description: NB-UVB Phototherapy twice per week for 6 months until completing 48 sessions. Initial dose of 200 mJ/cm² with a 10-20% increase to the previous session. Maximum dose for face and neck is 1500 mJ/cm² and 3000 mJ/cm² for the rest of the body.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered orally daily for 6 months
Study: NCT06229925

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental Stimulation
Description: Application of active direct current stimulation for 20 minutes, at an intensity of 2mA, with 30s of ramp up and ramp down, for 5 consecutive days. The anode will be positioned on M1 (C3) contralateral to the painful shoulder; The reference electrode (cathode) will be placed in the supraorbital region contralateral to the anode (Fp2). Direct current will be delivered through two 35cm2 surface sponge electrodes (7x5) soaked in saline solution, using a portable neuromodulator. During the entire stimulation, volunteers will remain seated in an air-conditioned and quiet place.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Stimulation
Description: Application of active direct current stimulation for 20 minutes, at an intensity of 2mA, for 5 consecutive days, administered in the same way as the experimental intervention. However, the stimulator will be turned off after 30 seconds and the volunteers will not receive current for the rest of the session.
Study: NCT04875793

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Stool for Occult Blood Test and Colonoscopy with comprehensive medical checkups
Description: participants will be drawn from all public government institutions inside Tabuk city(outreach). The institution head will be requested to give wellness cards to the eligible employee to receive comprehensive testing for free in addition to CRC test in selected public health centres.
Study: NCT05756530

Intervention type: OTHER
Intervention: Affective touch paradigm
Description: Affective touch paradigm: experimental stimuli will include the touch of a soft cosmetic, a hand, which will be both expected to resemble affective pleasant stimulations, and a plastic stick with a rounded tip, as a control (non-affective) condition. Two speeds of stimulation will be adopted i) slow affective stimuli delivered at 3 cm/s and fast non-affective stimuli, delivered at non-optimal speed (18 cm/s). An imagery version of the task will be also administered: blindfolded participants will be asked to image the touches on their left forearm.~After each (actual or imagined) tactile stimulus, individuals will rate the experience level of pleasantness.~As part of the protocol, they will fill out two psychological questionnaires, assessing the level of social anhedonia and the amount and characteristics of the lifespan experiences of affective touch in close relationships.

Intervention type: OTHER
Intervention: Affective touch paradigm
Description: Affective touch paradigm: experimental stimuli will include the touch of a soft cosmetic, a hand, which will be both expected to resemble affective pleasant stimulations, and a plastic stick with a rounded tip, as a control (non-affective) condition. Two speeds of stimulation will be adopted i) slow affective stimuli delivered at 3 cm/s and fast non-affective stimuli, delivered at non-optimal speed (18 cm/s). An imagery version of the task will be also administered: blindfolded participants will be asked to image the touches on their left forearm.~After each (actual or imagined) tactile stimulus, individuals will rate the experience level of pleasantness.~As part of the protocol, they will fill out two psychological questionnaires, assessing the level of social anhedonia and the amount and characteristics of the lifespan experiences of affective touch in close relationships.
Study: NCT06374615

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: IgG and IgM search for specific Tick-Borne Patogens
Description: Ticks will be classified based on morphological characteristics by microscopy observation.~For TBP detection by molecular test, Nucleic acid extraction will be performed on ticks lysate or blood using kits MagMAX TM Viral/Pathogen Nucleic Acid Isolation Kit (Thermo Fisher Scientific) on MagEX STARlet platform from Hamilton. Species identification by molecular method will be performed by Sanger sequencing for Rickettsiae and Babesia, and Multi-Locus Sequence Typing will be used to characterize Borrelia.~Serum samples collected throughout the study will be tested to assess any seroconversions during the follow-up period.~Samples will be tested for the presence of specific IgG and IgM for the following TBPs: TBEV, R. typhi. R. conorii, Borrelia spp, Anaplasma, Ehrlichia and Babesia.
Study: NCT05586022

Intervention type: PROCEDURE
Intervention: endovascular revascularization
Description: percutaneous balloon dilatation, stent implantation, plaque resection, laser plasty, cutting balloon, drug balloon, cryoballoplasty, thrombolytic therapy with drugs or thrombectomy
Study: NCT05227820

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NE3107
Description: Participants will take 20mg twice daily (BID) approximately 12 hours apart. The dose will be stable the duration of the study intervention (3 months)
Study: NCT05956678

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)
Description: TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)
Description: The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.
Study: NCT05330754

Intervention type: DIETARY_SUPPLEMENT
Intervention: Caffeine intake in mg
Description: Preanesthetic check-up was done. Average daily caffeine consumption in mg was calculated according to caffeine content in consumed drinks as estimated by Food Data Central.

Intervention type: DIETARY_SUPPLEMENT
Intervention: Caffeine intake in mg
Description: Preanesthetic check-up was done. Average daily caffeine consumption in mg was calculated according to caffeine content in consumed drinks as estimated by Food Data Central.

Intervention type: DIETARY_SUPPLEMENT
Intervention: Caffeine intake in mg
Description: Preanesthetic check-up was done. Average daily caffeine consumption in mg was calculated according to caffeine content in consumed drinks as estimated by Food Data Central.
Study: NCT05530681

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Questionnaire
Description: The survey consists in standardized and validated questionnaires on urinary function (ICIQ-SF, 4 items), bowel function (SMIS, 7 items and PAC-SYM, 12 items), symptoms of prolapse (POPDI, 6 items) and sexual function (Female Sexual Function Index FSFI, 19 items and Female Sexual Distress Scale - Revised FSDS-R, 13 items). questionnaire will be used at recruitment, at the postpartum visit, at the first annual follow-up visit.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Pelvic floor ultrasound
Description: Pelvic floor ultrasound is the preferred imaging modality for documenting pelvic floor anatomy during pregnancy or after delivery. This examination is routinely performed in the outpatient clinic during patient visits (including the one year check-up after delivery). The technique used to assess the pelvic floor is described in detail in the 2019 practice parameters issued by IUGA.
Study: NCT05258864

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Check Your Drinking (CYD)
Description: The CYD is a brief online intervention designed to provide personalized normative feedback aimed at motivating reductions in drinking
Study: NCT06227247

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meals4Moms Intervention
Description: A community-based, healthy living program including continued gestational diabetes (GDM) education, physical activity level monitoring, and delivery of medically-tailored GDM meals for the management of gestational diabetes in pregnant people.
Study: NCT05194748

Intervention type: OTHER
Intervention: No intervention, observational only
Description: No intervention, observational only

Intervention type: OTHER
Intervention: No intervention, observational only
Description: No intervention, observational only
Study: NCT05670171

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Debulking Atherectomy
Description: Excimer laser atherectomy combined with drug-coated balloon angioplasty

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stent Angioplasty
Description: Nickel-titanium self-expanding bare stent
Study: NCT06497322

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise intervention - High intensity interval training on a cycle-ergometer
Description: The experimental group starts with 5 minutes of unloaded cycling, followed by 3 × 3-minute HIIT training sequences alternating between: i) 30 seconds at 90% of maximal PO (70 rpm for 30 seconds) and ii) 30 seconds of light pedaling at 20% of PO). Recent work suggests that this high-intensity approach to aerobic exercise is feasible and safe, even during acute oncology treatment. The HIIT sequences are interspersed with two 3-minute cycling sessions at moderate intensity. The training session will be concluded with a 5-minute cool-down by cycling (light pedaling) and stretching. This protocol will be performed twice a week throughout the study, and all patients who reach an 80% adherence threshold for the exercise intervention will be included in the final analysis.
Study: NCT05285085

Intervention type: DRUG
Intervention: Statin
Description: Statin use

Intervention type: DRUG
Intervention: Statin
Description: Statin use

Intervention type: DRUG
Intervention: Statin
Description: Statin use
Study: NCT05893264

Intervention type: OTHER
Intervention: Data collection
Description: Several data will be collected such as:~Age, weight, height, gender, previous spine surgery, skoliosis (Y/N), palpable spinous process (Y/N), experience in years of anesthesiologist, spine level of epidural placement~and the following sonographic parameters at the level of epidural placement: skin-spinous process distance (cm), skin-transversous process distance (cm), erector spinae plane distance (cm), superior to inferior spinous process distance (cm)
Study: NCT06399822

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Nail capillaroscopy
Description: The intervention studied as part of the project is capillaroscopy. This examination consists of visualizing the capillaries located at the base of the nail using a device called a capillaroscope. This device magnifies the image of the capillaries to clearly visualize them. Capillaries are the smallest blood vessels, which allow the passage of only one red blood cell at a time. At the nail bed, they form a network of loops and are aligned next to each other. This alignment allows them to be viewed over their entire length. Researchers have described abnormalities in capillaries that are associated with certain diseases involving microvascular damage.~The results of capillaroscopy will be reported qualitatively, for all eight long fingers examined.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Nail capillaroscopy
Description: The intervention studied as part of the project is capillaroscopy. This examination consists of visualizing the capillaries located at the base of the nail using a device called a capillaroscope. This device magnifies the image of the capillaries to clearly visualize them. Capillaries are the smallest blood vessels, which allow the passage of only one red blood cell at a time. At the nail bed, they form a network of loops and are aligned next to each other. This alignment allows them to be viewed over their entire length. Researchers have described abnormalities in capillaries that are associated with certain diseases involving microvascular damage.~The results of capillaroscopy will be reported qualitatively, for all eight long fingers examined.
Study: NCT05865639

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Description: Three weekly, supervised exercise sessions with aerobic exercise. Each session will last for 60-65 minutes, each period will be consist of 5 min warm up, 45 min formal training and 5-10 min relaxation training. Intervention period will be eight weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Description: Three weekly, supervised exercise sessions with aerobic exercise. Each session will last for 60-65 minutes, each period will be consist of 5 min warm up, 45 min formal training and 5-10 min relaxation training. Intervention period will be eight weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time Restricted Fasting
Description: Restricted daily window of caloric intake to maximum 8 hours. Intervention period will be eight weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time Restricted Fasting
Description: Restricted daily window of caloric intake to maximum 8 hours. Intervention period will be eight weeks.
Study: NCT05123690

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neurofeedback
Description: A device that assists in training patients in relaxing.
Study: NCT04900090

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Epidemiological study
Description: * Clinical phenotypic assessment and neurosensory measures~* Biological, genetic and metabolomic evaluation~* Questionnaires (quality of life, gout, life habit, comorbidities)~* Morphological evaluation by Dual-energy CT scan

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Epidemiological study
Description: * Clinical phenotypic assessment and neurosensory measures~* Biological, genetic and metabolomic evaluation~* Questionnaires (quality of life, gout, life habit, comorbidities)~* Morphological evaluation by Dual-energy CT scan
Study: NCT04534010

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NACgraft
Description: Patients requiring reconstruction of their nipple and areola have a NACgraft surgically implanted on their breasts. A NACgraft is a novel decellularized cadaveric implant derived from human nipples.
Study: NCT05735925

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Skin Swab & Skin Biopsies & Blood Sample
Description: These intervention will be necessary to phenotype the immune cells that are present in the skin and blood of HS patients